Condition 1: COVID-19. Condition 2: Cough. Condition 3: Shortness of breath. Condition 4: Fever. COVID-19 Cough Shortness of breath Fever, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All patients with corona (confirmed by test or CT) who have one of the clinical manifestations (shortness of breath and cough). Patients hospitalized
Exclusion criteria
Exclusion criteria: Any allergies to Almonds sweet or other foods Patients who ate Almonds sweet regularly Inability to take medication orally Diabetic patients Taking Opioid medications Use of Antitussive products Suffering from other respiratory diseases Hospitalization in the intensive care unit
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity shortness of breath. Timepoint: At the beginning of the study, 3 and 6 days after the start using product. Method of measurement: Dyspnoea-12 questionnaire.;Severity of cough. Timepoint: At the beginning of the study, 3 and 6 days after the start using product. Method of measurement: Leicester Cough Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sleep Quality. Timepoint: At the beginning of the study, 3 and 6 days after the start of product consumption. Method of measurement: Petersburg Sleep Quality Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahid Beheshti University of Medical Sciences